Cargando…
Dapagliflozin induces vasodilation in resistance-size mesenteric arteries by stimulating smooth muscle cell K(V)7 ion channels
Dapagliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor that, in addition to glucose reduction, lowers systemic blood pressure. Here, we investigated if dapagliflozin could directly relax small mesenteric arteries that control peripheral vascular resistance and blood pressure, and the un...
Autores principales: | Hasan, Ahasanul, Menon, Sreelakshmi N., Zerin, Farzana, Hasan, Raquibul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131249/ https://www.ncbi.nlm.nih.gov/pubmed/35647331 http://dx.doi.org/10.1016/j.heliyon.2022.e09503 |
Ejemplares similares
-
Empagliflozin Relaxes Resistance Mesenteric Arteries by Stimulating Multiple Smooth Muscle Cell Voltage-Gated K(+) (K(V)) Channels
por: Hasan, Ahasanul, et al.
Publicado: (2021) -
Neflamapimod induces vasodilation in resistance mesenteric arteries by inhibiting p38 MAPKα and downstream Hsp27 phosphorylation
por: Pandey, Ajay K., et al.
Publicado: (2022) -
Canagliflozin ameliorates renal oxidative stress and inflammation by stimulating AMPK–Akt–eNOS pathway in the isoprenaline-induced oxidative stress model
por: Hasan, Raquibul, et al.
Publicado: (2020) -
Canagliflozin attenuates isoprenaline-induced cardiac oxidative stress by stimulating multiple antioxidant and anti-inflammatory signaling pathways
por: Hasan, Raquibul, et al.
Publicado: (2020) -
Ca(2+) Regulation of TRP Ion Channels
por: Hasan, Raquibul, et al.
Publicado: (2018)